This document summarizes research on the RNLAB toxin-antitoxin operon from E. coli. The objective was to determine if alternative dimerization is required for activity and inhibition of the HEPN ribonuclease RnlA. Various techniques were used, including PCR, cell-free expression of the RnlB antitoxin, Western blot, in vivo toxicity assays, and electrophoresis. The results showed that RnlB inhibits the endoribonuclease activity of RnlA. The conclusions discuss how understanding these defense mechanisms could help develop new therapies against bacterial infections and further genetic research.